Pfizer, Arvinas breast cancer therapy approved by FDA
Digest more
The pharmaceutical giant just extended the lifespan of one of its top drugs.
Pfizer is hoping for earlier use of Elrexfio (elranatamab) in relapsed or refractory multiple myeloma (RRMM) after the drug ...
As Pfizer gears up to defend its patents on transthyretin amyloid cardiomyopathy (ATTR-CM) med tafamidis in court this week, ...
Pfizer Inc. (NYSE: PFE) today announced that it has entered into settlement agreements with generic drug manufacturers Dexcel Pharma, Hikma Pharmaceuticals and Cipla Ltd, regarding lawsuits filed in ...
The pharmaceutical company has been investing in its future growth, but whether its efforts will pay off is a big question ...
Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle ...
Lyme disease is the most common tick-borne infectious disease in the United States. There is no vaccine to protect against it in humans. Biopharmaceutical company Pfizer and Valne ...
April 28 (Reuters) - Pfizer said on Tuesday it has settled patent disputes with three generic drugmakers over its blockbuster ...
Pfizer has spent the past few years trying to convince investors that its post-pandemic business can stand on its own, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results